Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medtronic (NY:MDT)

89.22 -0.51 (-0.57%)
Official Closing Price Updated: 7:00 PM EDT, Jul 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
MEDTRONIC PLC (NYSE:MDT) – A Reliable Dividend Stock Worth Considering
MEDTRONIC PLC (NYSE:MDT) offers a solid 3.18% dividend yield, strong profitability, and reasonable valuation, making it a candidate for dividend investors. The company has a reliable payout history and... 
Via Chartmill
5 Robotics Stocks to Buy for the Future of Automation
Robotics adoption is accelerating globally, with AI, automation, and real-time data processing reshaping industries from healthcare to manufacturing. 
Via MarketBeat
Topics Artificial Intelligence
Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast
Bank of America names its highest-conviction stock ideas for Q3 2025—8 Buys and 2 Underperforms. Boeing, Cisco, and Datadog top the list. 
Via Benzinga
Medtronic Stock Is Climbing Friday: What's Going On?
CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward broader adoption. 
Via Benzinga
CMS’s Initial Proposal To Cover Renal Denervation A Win For Medtronic, Says Analysts
Via Stocktwits
Looking Into Medtronic's Recent Short Interest
Via Benzinga
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now
Via The Motley Fool
What Is Considered a Good Dividend Stock? 3 Healthcare Stocks That Fit the Bill
A steady dose of quality companies will keep your portfolio growing big and strong. 
Via The Motley Fool
Topics Intellectual Property
1 No-Brainer Dividend Stock to Buy Now and Hold Forever
Via The Motley Fool
Topics Government World Trade
Medtronic Names CFO For New Diabetes Company Ahead Of Intended Spin-Off
Chad Spooner’s appointment will be effective July 14, and he will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives. 
Via Stocktwits
Merit Medical Names Medtronic Veteran Martha Aronson As Next CEO, Projects Strong Outlook
Merit Medical appoints Medtronic veteran Martha Aronson as CEO, projecting strong Q2 revenue above estimates. 
Via Benzinga
Merit Medical Stock Soars After Hours As Better-Than-Expected Q2 Guidance Outweighs CEO Exit
The company expects second-quarter revenue to grow by as much as 14% year-over-year, with foreign exchange headwinds expected to trim approximately $2.3 million from the top line. 
Via Stocktwits
Bond Introduces World’s First Perpetual Smart Ring with Patent-Pending LifeDrive System
Via Get News
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors 
Via MarketBeat
Topics Lawsuit
This Oracle Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Via Benzinga
Beyond The Numbers: 6 Analysts Discuss Medtronic Stock
Via Benzinga
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them. 
Via The Motley Fool
G3 Partners Opens Procomer Office in Silicon Valley to Accelerate U.S. Investment into Costa Rica
Via Press Release Distribution Service
FDA Sounds Alarm After 33 Injuries Tied To Medtronic Device Malfunction
FDA highlights risks from recalled Medtronic devices tied to esophageal injuries and faulty cannulas, with serious health concerns and product warnings issued. 
Via Benzinga
Abbott, Dexcom Draw Retail Buzz As RFK Jr. Urges Americans To Embrace Health Wearables
Retail sentiment surged on Stocktwits, with message volume jumping 1,600% for Abbott and 750% for Dexcom. 
Via Stocktwits
Texas Instruments Stock: Congress Likes It, Should You Too?
Texas Instruments is well-positioned to meet the increasing demand for domestically produced semiconductor products across sectors and industries. 
Via MarketBeat
Topics Retirement
MEDTRONIC PLC (NYSE:MDT) - A Reliable Dividend Stock With Strong Profitability
MEDTRONIC PLC (NYSE:MDT) offers a strong 3.31% dividend yield, reliable payout history, and solid profitability, making it a compelling choice for dividend investors. 
Via Chartmill
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
Via The Motley Fool
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term? 
Via MarketBeat
Topics Earnings World Trade
Texas Instruments Announces $60 Billion US Semiconductor Manufacturing Boost
Texas Instruments plans to invest $60 billion to expand U.S. chip manufacturing, creating 60,000 jobs. Apple, Ford, Medtronic, NVIDIA, and SpaceX support the initiative. 
Via Benzinga
Texas Instruments Unveils $60B Plan To Build 7 US Chip Factories Amid Trump Manufacturing Push
The company said its seven factories will span three manufacturing mega-sites and manufacture “hundreds of millions” of U.S.-made chips daily, while creating over 60,000 new U.S. jobs. 
Via Stocktwits
Topics Government
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END 
Via FinancialNewsMedia
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst
Intuitive Surgical remains in focus as analysts weigh reprocessing risks after Restore Robotics secures FDA clearance for remanufactured tools. 
Via Benzinga
Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities
From FN Media Group LLC
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback